Impact of preoperative weight loss achieved by gastric balloon on peri- and postoperative outcomes of bariatric surgery in super-obese patients: a retrospective matched-pair analysis.
Intragastric balloon
Obesity
Roux-en-Y gastric bypass
Sleeve gastrectomy
Super-obesity
Journal
Langenbeck's archives of surgery
ISSN: 1435-2451
Titre abrégé: Langenbecks Arch Surg
Pays: Germany
ID NLM: 9808285
Informations de publication
Date de publication:
Aug 2022
Aug 2022
Historique:
received:
29
10
2021
accepted:
14
02
2022
pubmed:
9
3
2022
medline:
26
8
2022
entrez:
8
3
2022
Statut:
ppublish
Résumé
An intragastric balloon is used to cause weight loss in super-obese patients (BMI > 60 kg/m In this retrospective, single-center study, the effects of intragastric balloon in 26 patients (BMI 69.26 ± 6.81) on weight loss after bariatric surgery (primary endpoint), postoperative complications within 30 days, hospital readmission, operation time, and MTL30 (secondary endpoints) were evaluated. Fifty-two matched-pair patients without intragastric balloon prior to bariatric surgery were used as controls. Intragastric balloon resulted in a weight loss of 17.3 ± 14.1 kg (BMI 5.75 ± 4.66 kg/m A multi-stage therapeutic approach with gastric balloon prior to bariatric surgery in super-obese patients may be effective to facilitate safe surgery. However, with the gastric balloon, pre-treated patients experienced an attenuated postoperative weight loss with an earlier nadir and earlier body weight regain. This should be considered when choosing the appropriate therapeutic regime and managing patients' expectations.
Sections du résumé
BACKGROUND
BACKGROUND
An intragastric balloon is used to cause weight loss in super-obese patients (BMI > 60 kg/m
METHODS
METHODS
In this retrospective, single-center study, the effects of intragastric balloon in 26 patients (BMI 69.26 ± 6.81) on weight loss after bariatric surgery (primary endpoint), postoperative complications within 30 days, hospital readmission, operation time, and MTL30 (secondary endpoints) were evaluated. Fifty-two matched-pair patients without intragastric balloon prior to bariatric surgery were used as controls.
RESULTS
RESULTS
Intragastric balloon resulted in a weight loss of 17.3 ± 14.1 kg (BMI 5.75 ± 4.66 kg/m
CONCLUSION
CONCLUSIONS
A multi-stage therapeutic approach with gastric balloon prior to bariatric surgery in super-obese patients may be effective to facilitate safe surgery. However, with the gastric balloon, pre-treated patients experienced an attenuated postoperative weight loss with an earlier nadir and earlier body weight regain. This should be considered when choosing the appropriate therapeutic regime and managing patients' expectations.
Identifiants
pubmed: 35257223
doi: 10.1007/s00423-022-02472-1
pii: 10.1007/s00423-022-02472-1
pmc: PMC9399010
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1873-1879Informations de copyright
© 2022. The Author(s).
Références
J Minim Access Surg. 2019 Jan-Mar;15(1):1-7
pubmed: 29737316
Chirurg. 2017 Nov;88(11):977-982
pubmed: 28761965
Surg Obes Relat Dis. 2013 Sep-Oct;9(5):617-22
pubmed: 23312757
Trends Endocrinol Metab. 2020 Jun;31(6):395-397
pubmed: 32396841
Lancet. 2021 May 15;397(10287):1830-1841
pubmed: 33965067
Obes Surg. 2018 Nov;28(11):3678-3690
pubmed: 30121854
Ci Ji Yi Xue Za Zhi. 2019 Sep 16;31(4):254-259
pubmed: 31867254
World J Surg. 2018 Apr;42(4):1065-1072
pubmed: 29018909
Obes Facts. 2009;2 Suppl 1:41-8
pubmed: 20124778
Obes Surg. 2006 Sep;16(9):1135-7
pubmed: 16989695
JAMA. 2018 Jan 16;319(3):255-265
pubmed: 29340679
Surgery. 2007 Oct;142(4):621-32; discussion 632-5
pubmed: 17950357
Surg Endosc. 2021 Jun;35(6):3115-3121
pubmed: 32572625
Int J Environ Res Public Health. 2017 Aug 30;14(9):
pubmed: 28867791
Pol Przegl Chir. 2011 Apr;83(4):181-7
pubmed: 22166356
Clin Gastroenterol Hepatol. 2018 Jul;16(7):1073-1080.e1
pubmed: 29425781
Rev Esp Enferm Dig. 2017 Apr;109(4):256-264
pubmed: 28229608
J Am Coll Surg. 2014 Oct;219(4):725-34.e3
pubmed: 25154670
Obes Surg. 2021 May;31(5):2319-2323
pubmed: 33151519
Surg Obes Relat Dis. 2014 May-Jun;10(3):516-23
pubmed: 24951069
Lancet. 2015 Sep 5;386(9997):964-73
pubmed: 26369473
World J Gastroenterol. 2016 Jun 28;22(24):5495-504
pubmed: 27350727
Obes Surg. 2012 May;22(5):777-82
pubmed: 22350986
Obes Surg. 2020 Jan;30(1):119-126
pubmed: 31529393
BMJ Open. 2016 Feb 08;6(2):e009389
pubmed: 26857104
Obes Surg. 2019 Jun;29(6):1932-1936
pubmed: 30806915
Obes Surg. 2012 Jul;22(7):1126-34
pubmed: 22527591
Obes Surg. 2017 Apr;27(4):902-909
pubmed: 27664095
Obesity (Silver Spring). 2016 Mar;24(3):654-60
pubmed: 26847390
Obes Surg. 2003 Oct;13(5):734-8
pubmed: 14627468
Adv Ther. 2018 Jan;35(1):1-4
pubmed: 29285708
Lancet. 2009 Mar 28;373(9669):1083-96
pubmed: 19299006